Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
31 results:
1. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the akt/mTOR/S6K signalling pathway.
Li N; Wang Y; Liu L; Wang P; Wu X
J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
[TBL] [Abstract] [Full Text] [Related]
2. [High clinical value of bone scintigraphy as a staging method for breast cancer].
Eilsberger F; Girmond C; Boekhoff J; Librizzi D; Luster M; Pfestroff A
Nuklearmedizin; 2022 Aug; 61(4):308-313. PubMed ID: 35388441
[TBL] [Abstract] [Full Text] [Related]
3. GPR116 overexpression correlates with poor prognosis in gastric cancer.
Zheng T; Sun M; Liu L; Lan Y; Wang L; Lin F
Medicine (Baltimore); 2021 Dec; 100(48):e28059. PubMed ID: 35049225
[TBL] [Abstract] [Full Text] [Related]
4. N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on breast cancer.
Song Y; Zheng C; Tao Y; Huang R; Zhang Q
Med Sci Monit; 2021 Aug; 27():e929615. PubMed ID: 34349094
[TBL] [Abstract] [Full Text] [Related]
5. staging computerized tomography before delayed breast reconstruction could alter the management plan.
Iqbal J; Malahias MN; Alsharkawy K; Youssef S; Trigkatzis P; Shimal A; Pradhan P; Kalkat M; Khalil HH
J Plast Reconstr Aesthet Surg; 2021 Dec; 74(12):3289-3299. PubMed ID: 34210626
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early breast cancer.
Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
[TBL] [Abstract] [Full Text] [Related]
7. Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.
Ji P; Gong Y; Jiang CC; Hu X; Di GH; Shao ZM
Cancer Med; 2020 Mar; 9(5):1922-1936. PubMed ID: 31960597
[TBL] [Abstract] [Full Text] [Related]
8. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.
Keup C; Benyaa K; Hauch S; Sprenger-Haussels M; Tewes M; Mach P; Bittner AK; Kimmig R; Hahn P; Kasimir-Bauer S
Cell Mol Life Sci; 2020 Feb; 77(3):497-509. PubMed ID: 31254045
[TBL] [Abstract] [Full Text] [Related]
9. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma.
Zhang S; He J; Jia Z; Yan Z; Yang J
Urol Oncol; 2018 May; 36(5):243.e9-243.e20. PubMed ID: 29503142
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the akt/GSK-3β Pathway in Gastric cancer.
Hua K; Li Y; Zhao Q; Fan L; Tan B; Gu J
Med Sci Monit; 2018 Jan; 24():149-160. PubMed ID: 29306955
[TBL] [Abstract] [Full Text] [Related]
11. cancer Yield of Incidental breast Lesions Detected on Chest Computed Tomography.
Healey TT; Agarwal S; Patel R; Ratanaprasatporn L; Ratanaprasatporn L; Lourenco AP
J Comput Assist Tomogr; 2018; 42(3):453-456. PubMed ID: 29016373
[TBL] [Abstract] [Full Text] [Related]
12. A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.
Wang W; Wang Z; Zhao J; Wei M; Zhu X; He Q; Ling T; Chen X; Cao Z; Zhang Y; Liu L; Shi M
Oncotarget; 2016 Sep; 7(39):63526-63536. PubMed ID: 27556859
[TBL] [Abstract] [Full Text] [Related]
13. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of C35 in breast carcinomas is associated with tumor progression and lymphnode metastasis.
Yin K; Ba Z; Li C; Xu C; Zhao G; Zhu S; Yan G
Biosci Trends; 2015 Dec; 9(6):386-92. PubMed ID: 26781796
[TBL] [Abstract] [Full Text] [Related]
15. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K; Faivre L; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houede N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Chinet-Charrot P; Legouffe E; Lagrange JL; Linassier C; Deplanque G; Beuzeboc P; Davin JL; Martin AL; Habibian M; Laplanche A; Culine S
Lancet Oncol; 2015 Jul; 16(7):787-94. PubMed ID: 26028518
[TBL] [Abstract] [Full Text] [Related]
16. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
Aleskandarany MA; Negm OH; Green AR; Ahmed MA; Nolan CC; Tighe PJ; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2014 Jun; 145(2):339-48. PubMed ID: 24771047
[TBL] [Abstract] [Full Text] [Related]
17. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
[TBL] [Abstract] [Full Text] [Related]
18. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
[TBL] [Abstract] [Full Text] [Related]
19. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract] [Full Text] [Related]
20. Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis.
Wolff C; Malinowsky K; Berg D; Schragner K; Schuster T; Walch A; Bronger H; Höfler H; Becker KF
J Pathol; 2011 Jan; 223(1):54-63. PubMed ID: 21125664
[TBL] [Abstract] [Full Text] [Related]
[Next]
